Cost‑utility analysis of routine oral anticoagulation for low‑risk patients undergoing cardioversion for atrial fibrillation and flutter


Journal article


S. Chhabra, K. Yadav, M. Cortel-LeBlanc, A. Costello, I. Stiell, K. Thavorn
Canadian Journal of Emergency Medicine, 2025


Cite

Cite

APA   Click to copy
Chhabra, S., Yadav, K., Cortel-LeBlanc, M., Costello, A., Stiell, I., & Thavorn, K. (2025). Cost‑utility analysis of routine oral anticoagulation for low‑risk patients undergoing cardioversion for atrial fibrillation and flutter. Canadian Journal of Emergency Medicine. https://doi.org/10.1007/s43678-025-00991-6


Chicago/Turabian   Click to copy
Chhabra, S., K. Yadav, M. Cortel-LeBlanc, A. Costello, I. Stiell, and K. Thavorn. “Cost‑Utility Analysis of Routine Oral Anticoagulation for Low‑Risk Patients Undergoing Cardioversion for Atrial Fibrillation and Flutter.” Canadian Journal of Emergency Medicine (2025).


MLA   Click to copy
Chhabra, S., et al. “Cost‑Utility Analysis of Routine Oral Anticoagulation for Low‑Risk Patients Undergoing Cardioversion for Atrial Fibrillation and Flutter.” Canadian Journal of Emergency Medicine, 2025, doi:10.1007/s43678-025-00991-6.


BibTeX   Click to copy

@article{s2025a,
  title = {Cost‑utility analysis of routine oral anticoagulation for low‑risk patients undergoing cardioversion for atrial fibrillation and flutter},
  year = {2025},
  journal = {Canadian Journal of Emergency Medicine},
  doi = {10.1007/s43678-025-00991-6},
  author = {Chhabra, S. and Yadav, K. and Cortel-LeBlanc, M. and Costello, A. and Stiell, I. and Thavorn, K.}
}


Share

Tools
Translate to